The apoptosis and anti-angiogenesis abilities of oral paclitaxel in-vivo were evaluated by terminal deoxynucleotidyl transferase dUTP nick-end labelling (TUNEL) assay and anti-CD31 immunochemical staining in tumour tissues. Here, PECAM1 is linked to neoplasm.